The NCCN annual meeting grew in attendance again this year. In these days of slashed budgets it is rare to see growth in travel, and perhaps that speaks to the relevance of the NCCN meeting, both clinically and economically, to today’s oncology environment. Increasingly, NCCN guidelines are playing an important role in the “value” discussion. [...]
It’s notable that in President Obama’s recent, first speech before Congress, the only disease mentioned in addressing the country’s urgent need for health care reform was cancer. Obama pledged “to seek a cure for cancer in our time,” a tall order that has so far eluded researchers. Each cancer drug approval and every trial represents [...]
OBR green is our dynamic, eco-friendly companion to our print journal Oncology Business Review. Register to begin receiving OBR green today. View the Most Recent Issue»
